BMY stock was moving higher into the close on November 26, 2019, on bullish options flow.

Bullish options flow detected in BMY stock on November 26, 2019

Click here to download the complete options flow in BMY on November 26, 2019, in CSV format.

On November 25, 2019, in an interview on CNBC’s Mad Money, Bristol-Myers (BMY) CEO Giovanni Caforio said: We are working on seven new medicines to launch… We have a great pipeline and great people… We are positioned to succeed… Our position in cell therapy is one of the great programs we have right now… We recently announced a partnership with Fitbit (FIT)… We think we can grow through technology… The next frontier for growth is the early stage of cancer… We take a responsible approach to drug pricing, but we see a need for change in the system…Renewing our portfolio was really the rationale for acquiring Celgene (CELG).

finviz dynamic chart for  BMY
Bristol-Myers News